CRISPR Therapeutics AG (CRSP) Financials

CRSP Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 2.2 billion 346.8 million
2023-09-30 2.1 billion 359.0 million
2023-06-30 2.2 billion 381.0 million
2023-03-31 2.2 billion 389.5 million

CRSP Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -96.8 million 18.4 million
2023-09-30 -42.0 million 20.0 million
2023-06-30 -136.8 million 21.8 million
2023-03-31 5.7 million 20.9 million

CRSP Net Income

No data available :(

CRSP Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 1.7 billion - 238.6 million
2023-09-30 1.7 billion - 241.6 million
2023-06-30 1.8 billion - 245.2 million
2023-03-31 344.4 million - 240.3 million

CRSP Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 81.3 million
2023-09-30 79.4 million
2023-06-30 79.1 million
2023-03-31 78.7 million

CRSP Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 738000 95.1 million 16.5 million -
2023-09-30 2.1 million 90.7 million 18.3 million -
2023-06-30 3.6 million 101.6 million 19.0 million -
2023-03-31 3.1 million 99.9 million 22.4 million -

CRSP Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 200.0 million 20.0 million
2023-09-30 - 23.4 million
2023-06-30 70.0 million 44.6 million
2023-03-31 100.0 million 42.2 million

CRSP

Price: $55.07

52 week price:
37.55
91.10

Earnings Per Share: -1.94 USD

P/E Ratio: -15.08

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 1.2 million

Ebitda: -23.2 million

Market Capitalization: 5.0 billion

Links: